Deals

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery
Eli LillyHKG: 7666

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery

METiS TechBio (HKG: 7666), an innovative AI drug delivery company, announced a strategic collaboration with Eli Lilly and Company (NYSE: LLY) focused on the research and discovery of novel lipid…

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Shanghai Henlius and Alvogen Korea Ink Licensing Deal for HanSiZhuang (Serplulimab)
Alvogen KoreaHenlius Biotech

Shanghai Henlius and Alvogen Korea Ink Licensing Deal for HanSiZhuang (Serplulimab)

Zhejiang Jolly Pharma Invests in Lingyi Biotech for Gene Therapy Development
Jolly PharmaceuticalLingyi Biotechnology

Zhejiang Jolly Pharma Invests in Lingyi Biotech for Gene Therapy Development

LTZ Therapeutics Secures $40M Series A+ to Advance Immunotherapy Pipeline
BiotechFinance

LTZ Therapeutics Secures $40M Series A+ to Advance Immunotherapy Pipeline

Innate Pharma and Sanofi Restructure 2016 Research Agreement on CD123 ANKET Drug
Innate PharmaNASDAQ: SNY

Innate Pharma and Sanofi Restructure 2016 Research Agreement on CD123 ANKET Drug

Show More